Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

5 Nov 2018 07:00

RNS Number : 2648G
Cenkos Securities PLC
05 November 2018
 

 

 

 5 November 2018

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

The Board is pleased to announce that, subject to FCA approval, Jim Durkin is to be appointed as an Executive Director and to the position of Chief Executive Officer once regulatory approval has been received. In the interim period Anthony Hotson remains as the Company's Chief Executive Officer.

Jim, a founding shareholder of the Company, was formerly Cenkos' Chief Executive Officer in the period December 2011 to July 2017. Jim resigned as Chief Executive Officer in July 2017. Jim Durkin has over 30 years' experience in the UK securities industry. During his career he has had substantial experience originating and executing corporate finance transactions across a range of industries including insurance, property, financials and utilities.

The Board today also announces that Gerry Aherne, the Chairman of the Company has informed the Board that he will step down and retire from the Company with immediate effect.

The Board would like to thank Gerry for his commitment and contribution to the Company as Chairman over the past six years and wish him well in the future.

The Board will commence the search for a new Chairman. Jeff Hewitt a Non-executive Director has been appointed as the acting Chairman in the interim period.

Jeff Hewitt the acting Chairman commented that:

"We welcome Jim back to the Company and have every confidence in Jim in leading the Company going forward. Jim is well placed to undertake the role having previously been on the Board and has been actively involved in the successful management of the Company."

AIM Rules disclosure under Schedule 2(g) of the AIM Rules

James John Durkin (known as Jim Durkin) holds 4,985,831 ordinary shares of 1p each in the Company representing 9.01% of the issued share capital of the Company.

In addition to his appointment to the Board, James John Durkin, aged 58, holds or has held the following directorships or partnerships in the past five years:

Current directorships:

JDPL Limited

 

Previous directorships:

Cenkos Securities plc

Cenkos Nominee UK Limited resigned

Cenkos Fund Management Limited

JDPL 2 Limited

 

There is no further information that is required to be disclosed with regards to the appointment of Jim Durkin pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

For further information, please contact: 

 

Cenkos Securities plc

Jeff Hewitt, Acting Non- Executive Chairman

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABJBBTMBBMMJP
Date   Source Headline
13th May 202012:43 pmRNSBoard Update
13th May 20208:41 amRNSForm 8.5 (EPT/NON-RI)
12th May 20208:38 amRNSForm 8.5 (EPT/NON-RI)
11th May 20205:29 pmRNSPDMR Dealings
11th May 20205:21 pmRNSTR-1: Notification of major holdings
11th May 202010:29 amRNSForm 8.5 (EPT/NON-RI)
7th May 20206:06 pmRNSPDMR Shareholding
7th May 20206:06 pmRNSPDMR Shareholding
7th May 20208:51 amRNSForm 8.5 (EPT/NON-RI)
6th May 20208:47 amRNSForm 8.5 (EPT/NON-RI)
5th May 20208:27 amRNSForm 8.5 (EPT/NON-RI)
4th May 20208:50 amRNSForm 8.5 (EPT/NON-RI)
4th May 20208:49 amRNSForm 8.5 (EPT/NON-RI)
1st May 202012:12 pmRNSDirector Shareholding
1st May 20209:02 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20205:26 pmRNSDirector Shareholding
30th Apr 20205:24 pmRNSPDMR Shareholding
30th Apr 20208:26 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20207:00 amRNSAnnual Results for the year ended 31 December 2019
29th Apr 20208:28 amRNSForm 8.5 (EPT/NON-RI)
29th Apr 20208:25 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20203:06 pmRNSBoard Update
28th Apr 20209:16 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 20208:33 amRNSForm 8.5 (EPT/NON-RI)
24th Apr 20209:40 amRNSForm 8.5 (EPT/NON-RI)
24th Apr 20209:38 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 20209:59 amRNSEBT Share Purchase
23rd Apr 20209:09 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 202010:33 amRNSEBT Share Purchase
22nd Apr 20209:29 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20209:27 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20209:34 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20209:31 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20208:21 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20208:18 amRNSForm 8.5 (EPT/NON-RI)
17th Apr 20203:14 pmRNSBlock Admission Interim Review
17th Apr 20208:35 amRNSForm 8.5 (EPT/NON-RI)
17th Apr 20208:32 amRNSForm 8.5 (EPT/NON-RI)
14th Apr 20209:31 amRNSForm 8.5 (EPT/NON-RI)
9th Apr 20209:30 amRNSForm 8.5 (EPT/NON-RI)
8th Apr 202011:36 amRNSForm 8.5 (EPT/NON-RI)
7th Apr 20208:41 amRNSForm 8.5 (EPT/NON-RI)
6th Apr 20208:33 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 202010:16 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 20207:00 amRNSDeferral of publication of results and COVID 19
2nd Apr 20209:27 amRNSForm 8.5 (EPT/NON-RI)
1st Apr 20209:55 amRNSForm 8.5 (EPT/NON-RI)
30th Mar 20209:08 amRNSForm 8.5 (EPT/NON-RI)
27th Mar 20207:41 amRNSForm 8.5 (EPT/NON-RI)
26th Mar 20209:59 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.